MarketPeel
Insider Trading Intelligence
JH

Jeffrey S. Heier

OCUL
CHIEF SCIENTIFIC OFFICER · OCULAR THERAPEUTIX, INC · CIK 0001653082
FILING MIX · LIFETIME62%/38%
BUYS
13
SELLS
8
TOTAL VALUE
$359.7K
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
320,350
AVG SELL PX
$9.77
TRADE KIND
SHOWING 21 / 21
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
8 backtested trades · 8 horizons · 12 pending
Forward-return performance of every backtestable P/S trade by Jeffrey S. Heier, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d8+37.50%+7.58%+0.26%+7.32%+7.50%
14d8+0.00%+13.62%+0.40%+13.23%+15.19%
30d8+37.50%+7.29%+0.47%+6.82%+3.21%
60d8+50.00%+12.61%+2.03%+10.58%+6.22%
90d8+50.00%+15.10%+3.26%+14.30%+7.87%
180d8(1 pending)+71.43%+6.08%+3.84%+8.87%-5.22%
1y8(4 pending)+25.00%+45.75%+16.00%+29.75%+18.79%
2y8(7 pending)+100.00%+88.04%+36.96%+51.08%+51.08%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
OCUL · 320,350 shares · as of May 26, 2026
081,606163,213244,819326,425202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 13 buys / 8 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
3,018$8.20$24.7K320,350May 26, 2026May 28, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
3,057$8.28$25.3K323,368Feb 23, 2026Feb 25, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
79,112326,425Jan 2, 2026Jan 6, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
240,932240,932Jan 2, 2026Jan 6, 2026View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
3,469$12.04$41.8K245,940Nov 24, 2025Nov 26, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
10,502$11.04$115.9K249,409Oct 2, 2025Oct 6, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
3,063$12.04$36.9K259,911Aug 25, 2025Aug 27, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
3,024$7.18$21.7K262,974May 23, 2025May 27, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
3,061$6.87$21.0K265,998Feb 24, 2025Feb 26, 2025View →
OCUL
OCULAR THERAPEUTIX, INC
SALE10b5-1
10b5-1 plan
2,948$9.01$26.6K269,059Nov 25, 2024Nov 27, 2024View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
100,000272,007Oct 2, 2024Oct 4, 2024View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
200,000200,000Oct 2, 2024Oct 4, 2024View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
17,35017,350Aug 2, 2023Aug 18, 2023View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
12,00059,933Jun 14, 2023Jun 16, 2023View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
36,00036,000Jun 14, 2023Jun 16, 2023View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
16,00016,000Oct 17, 2022Oct 18, 2022View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
26,80026,800Jun 16, 2022Jun 21, 2022View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
8,93347,933Jun 16, 2022Jun 21, 2022View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASE
15,000$3.05$45.8K39,000May 12, 2022May 16, 2022View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
18,00018,000Jun 18, 2021Jun 22, 2021View →
OCUL
OCULAR THERAPEUTIX, INC
PURCHASEGRANT
Stock grant
18,00018,000Jun 25, 2020Jun 26, 2020View →
Other insiders · OCUL
Loading peer insiders…
About this filer
CIK 0001653082
ROLE
Chief Scientific Officer
PRIMARY
OCUL
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001653082DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback